AeroLeads people directory · profile
Rahul Saikia Email & Phone Number
Head of Mergers and Acquisitions, Chief Strategy Officer
at
Rising Pharmaceuticals
1 work email found
@risingpharma.com
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
Head of Mergers and Acquisitions, Chief Strategy Officer
Location
Hyderabad, Telangana, India
Who is Rahul Saikia? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Rahul Saikia is listed as Head of Mergers and Acquisitions, Chief Strategy Officer at Rising Pharmaceuticals, based in Hyderabad, Telangana, India. AeroLeads shows a work email signal at risingpharma.com and a matched LinkedIn profile for Rahul Saikia.
Rahul Saikia previously worked as Strategic Advisor at Grace Therapeutics and Strategic Advisor at Cronus Pharma Llc. Rahul Saikia holds Chartered Accountant, Accounting & Finance from Icai, Chartered Accountancy.
Company email context
Email format at Rising Pharmaceuticals
This section adds company-level context without repeating Rahul Saikia's masked contact details.
{first_initial}{last}@risingpharma.com
86% confidence
AeroLeads found 1 current-domain work email signal for Rahul Saikia. Compare company email patterns before reaching out.
Profile bio
About Rahul Saikia
Corporate Strategy and M&A professional focused on delivering value-enhancing strategic projects and executing strategic M&A transactions in the Pharmaceutical Industry - currently, Head of M&A, Strategic Alliances for Rising Pharmaceuticals. Before this, was Chief Strategy Officer at FDC Limited. Coming from a deep Investment banking background, employers include PwC Corporate Finance, ENAM Securities, SSKI, and ANZ Investment Bank. Prior corporate strategy, M&A at Pfizer India in the early stages of my career.Experienced in all aspects of deal origination and transaction execution encompassing initial assessment, due diligence (industry, company, accounting, legal), financial modeling, structuring, assistance in the investment committee/ board of directors process, closure, and follow-on transactions.Specialties: Transactions across capital markets, private equity, M&A, restructuring, and bankruptcy across geographies -US, India, UK, South Africa, and Bangladesh include companies in healthcare, utilities, infrastructure, real estate, transportation, retail, banks, insurance, microfinance, specialty finance, sports franchises, education.Additional expertise in creating and delivering financial modeling training for Investment Banking analysts, running an independent global ports M&A training program, and delivering Finance for Non-Finance programs to C-level executives.
Listed skills include Financial Modeling, Corporate Finance, Valuation, Investment Banking, and 45 others.
Current workplace
Rahul Saikia's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 22 years
Rahul Saikia work experience
A career timeline built from the work history available for this profile.
Head Of Mergers And Acquisitions, Chief Strategy Officer
Current• Instrumental in bringing HIG Capital as strategic investors into Rising Pharmaceuticals. • Drive M&A evaluation pursuits to acquiring corporate platforms, products.• Oversight in strategic initiatives around optimizing plant on-time project completion, manufacturing efficiencies, being US FDA inspection ready. • Strategic Advisor to group Animal Health Generics Co – Cronus Pharma – 6th rank in the number of Animal Health products approved in the US FDA Green Book
Jan 2020 - Present
Strategic Advisor
Current
Grace Therapeutics
Advisory role in the reverse merger of Group Entity Grace Therapeutics into Acasti Pharma - $138 million deal value .3 key assets - Subarachnoid Hemorrhage (SAH) – Intravenous Infusion, Ataxia-telangiectasia (A-T) - Oral Mucosal Spray, Post Herpetic Neuralgia (PHN) - Topical Spray being developed through the 505 B 2 route.
Feb 2020 - Present
Strategic Advisor
CurrentUS focussed animal health generics- ranked 6 in Products Approved in US FDA Green Book, state of the art US FDA approved plant in Hyderabad, front end in New Jersey, USA.
Feb 2020 - Present
Chief Strategy Officer
Net Income turnaround from a 10% YoY de growth at the time of joining to a 44% Net Income growth in the tenure of stint driven by: • Strategic transformation and revitalization of the India Domestic Branded Generics business driven by multiple levers – Sales Force Reorganization, Attrition Management, Sales Force Incentive realignment, Capacity Building, Building in monitoring processes. • Plant through put improvement to capitalize on short supply situations in key select products in the US Gx market. Transactions closed • Aceto Chapter 11 – part of Unsecured Creditors Committee represented broader unsecured creditor interests in addition to FDC s trade claims; achieved 100% recovery, approved sale (cumulative deal value $559 million) Chemicals to New Mountain Capital, Generic Rx – Rising Pharmaceuticals to Shore Suven.• Acquired pro biotic brand – Enteroplus from GSK Pharmaceuticals • Stake consolidation of South Africa Joint Venture.
Mar 2018 - Feb 2020
Feb 2015 - Mar 2018
Jan 2012 - Jan 2015
Vice President, Investment Banking
Origination responsibilities in FIG, infrastructure & healthcare for existing and new clients.Execution of M&A, capital markets and private equity transactions across sectors.
Dec 2006 - Jan 2012
Investment Banking Associate
Private equity growth capital for healthcare and infrastructure businesses.
2005 - 2006
~1 yr
Strategy & Business Development Associate
Strategic projects for Pfizer India (subsidiary of Pfizer Inc) which included M&A, alliance transactions and internal assignments on product portfolio management, optimizing supply chain efficiencies, achieving sales force productivity and pricing.
Dec 2004 - Dec 2005
Investment Banking Analyst
Investment Banking Analyst responsible for providing support on investment banking transactions encompassing industry/ company research, maintaining comparable trading/ transaction valuation data, preparing regulatory documents.
Jan 2004 - Dec 2004
Analyst
Trained with the Transaction Services team in PwC focussed on Due Diligence assignments on M&A transactions - sectors covered included Pharmaceuticals, Healthcare, Metals & Mining.
Jan 2002 - Dec 2003
4 education records
Rahul Saikia education
Chartered Accountant, Accounting & Finance
Icai, Chartered Accountancy
High School
Apeejay School
Education record
St Edmunds, Shillong
Bachelor Of Commerce, Accounting
Symbiosis International University
FAQ
Frequently asked questions about Rahul Saikia
Quick answers generated from the profile data available on this page.
What company does Rahul Saikia work for?
Rahul Saikia works for Rising Pharmaceuticals.
What is Rahul Saikia's role at Rising Pharmaceuticals?
Rahul Saikia is listed as Head of Mergers and Acquisitions, Chief Strategy Officer at Rising Pharmaceuticals.
What is Rahul Saikia's email address?
AeroLeads has found 1 work email signal at @risingpharma.com for Rahul Saikia at Rising Pharmaceuticals.
Where is Rahul Saikia based?
Rahul Saikia is based in Hyderabad, Telangana, India while working with Rising Pharmaceuticals.
What companies has Rahul Saikia worked for?
Rahul Saikia has worked for Rising Pharmaceuticals, Grace Therapeutics, Cronus Pharma Llc, Fdc Limited, and Pwc.
How can I contact Rahul Saikia?
You can use AeroLeads to view verified contact signals for Rahul Saikia at Rising Pharmaceuticals, including work email, phone, and LinkedIn data when available.
What schools did Rahul Saikia attend?
Rahul Saikia holds Chartered Accountant, Accounting & Finance from Icai, Chartered Accountancy.
What skills is Rahul Saikia known for?
Rahul Saikia is listed with skills including Financial Modeling, Corporate Finance, Valuation, Investment Banking, Mergers And Acquisitions, Private Equity, Investments, and Due Diligence.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial